Page last updated: 2024-08-17

cycloheximide and Hematologic Malignancies

cycloheximide has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hong, YS; Kim, KM; Lee, K; Park, HY1

Other Studies

1 other study(ies) available for cycloheximide and Hematologic Malignancies

ArticleYear
Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
    Experimental & molecular medicine, 2000, Dec-31, Volume: 32, Issue:4

    Topics: Apoptosis; bcl-2-Associated X Protein; Carrier Proteins; Cycloheximide; Fas Ligand Protein; fas Receptor; Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Membrane Glycoproteins; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatase, Non-Receptor Type 13; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Cell Surface; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Member 6b; Signal Transduction; Tumor Cells, Cultured

2000